COMMUNIQUÉS West-GlobeNewswire

Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
27/05/2025
BURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric [...]
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
27/05/2025
SOUTH SAN FRANCISCO, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that [...]
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
27/05/2025
Two Molecular Residual Disease (MRD) studies highlighting clinical data among seven new studies to be shared by Myriad and collaborators SALT LAKE CITY, May 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: [...]
PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call
27/05/2025
DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. , dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to [...]
Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
27/05/2025
Daix (France), New York City (New York, United States), May 27, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference »
27/05/2025
Daix (France), New York City (New York, Etats-Unis), le 27 mai 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
27/05/2025
Company announcement – No. 13 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 27 [...]
Dr. Jeremy Saul Announces National Scholarship Initiative to Support Aspiring Medical Students Pursuing Careers in Healthcare
27/05/2025
RUSSELLVILLE, Ark., May 27, 2025 (GLOBE NEWSWIRE) -- The Dr. Jeremy Saul Scholarship for Medical Students is now officially open for applications, offering aspiring undergraduate students across the United States the [...]
Dr. David Webb Launches National Scholarship Initiative to Support Aspiring Healthcare Professionals with a Vision to Serve
27/05/2025
PACATELLO, Idaho, May 27, 2025 (GLOBE NEWSWIRE) -- The Dr. David Webb Scholarship for Future Doctors is now accepting applications from students across the United States who are dedicated to building careers in [...]
Scientific Industries to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
27/05/2025
BOHEMIA, N.Y., May 27, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it will participate in [...]
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Keros’ Director Nominees
27/05/2025
Keros Board Best Equipped to Oversee Strategic Review Process and Execute on Ultimate Outcome of that Process ADAR1’s Disruptive and Self-Serving Campaign Stands to Jeopardize the Future Value Maximizing Potential of [...]
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
27/05/2025
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced its intention to file a Form 25 [...]
Nexzen Extracts Emerges as a Premium Name in Hemp-Derived Wellness Products
27/05/2025
Nexzen Extracts, a rising brand in the hemp and cannabis wellness space, has officially announced its expansion into the national market with a product line focused on purity, potency, and plant-based innovation [...]
CARBIOS signs its first biorecycled PET sales contracts with two global cosmetics leaders
27/05/2025
CARBIOS has signed two multi-year commercial contracts for biorecycled PET from its Longlaville plant, with L'ORÉAL and L'Occitane en Provence, and has moved forward with the execution of this future plant’s strategy [...]
CARBIOS signe ses premiers contrats de vente de PET biorecyclé avec deux leaders mondiaux de la cosmétique
27/05/2025
CARBIOS a signé deux contrats commerciaux pluriannuels de PET biorecyclé issu de l’usine de Longlaville, avec L’ORÉAL et L’Occitane en Provence et réalise une avancée dans l’exécution de sa stratégie pour sa future [...]
Avalo Therapeutics to Participate in Upcoming Investor Conferences
27/05/2025
WAYNE, Pa. and ROCKVILLE, Md., May 27, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that [...]
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense
27/05/2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS ◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $ [...]
Catheter Precision, Inc. Receives CE Mark for LockeT
27/05/2025
Opens Multi-Billion Market Opportunity for the Company First Order for 100 Units Received FORT MILL, S.C., May 27, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device [...]
Genmab to Participate in a Fireside Chat at the 46th Goldman Sachs Annual Global Healthcare Conference
27/05/2025
Media Release COPENHAGEN, Denmark; May 27, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its C hief F inancial O fficer Anthony Pagano will participate in a fireside chat at the 4 6 th Goldman Sachs Annual Global [...]

Pages